Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

NCT06180174 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

B Cell Lymphoma
Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: MC-1-50

Sponsor

Chongqing Precision Biotech Co., Ltd

Collaborators

[object Object]